just an off-hand question, but why favor this one over - say - JNJ? They all seem to trade for similar valuations (13x) but at least with JNJ you get wide diversification, a nice dividend, and as good or better financial metrics. Course, top line is not comparable, but you are unlikely to get specific product issues either - at least in total. Plus, I know for sure that the consumer side is absolutely undervalued (even if a smallish part of the company's business), though no clue on what would ever unlock it.I am likely just trying to justify my own moves. I own a bit position in MDT and as much it seems attractive at current prices I can't bring myself to own anymore. A problem with my own ignorance mostly, though being blunt JNJ is no easier to grasp either with 61b in revenue), but I own an outsized position in JNJ so.... anyway, you are a treasure kitkat. Thanks for the previous post.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat